Correlia's immunoassay tools reduce the time and cost for protein quantification. Their microscale technology enables measurements with broad dynamic range that are robust, automated, multiplexed, rapid, and require as little as 1 µL of starting sample when efficient protein quantitation is critical.
Fast assays complete as fast as 15min
Microscale: Data from as little as 1 uL of starting sample volume
Automated: Simple "walk-away, sample in/data out" operation, with minimal user intervention
Multiplexed: Up to 10 targets measured per sample
Broad Dynamic Range: up to 5 orders of magnitude
Within Correlia's consumable, target biomolecules are driven across a proprietary nanoporous substrate for highly efficient antigen-antibody binding.
mAb / Cytokine Response
Analyze Precious Samples：
They provide custom assay development and biosample testing services. Click here to know more.
Using a fraction of the sample, Correlia exceeds the detection range of gold-standard ELISA tests.
Correlia's first commercial instrument will be launched in 2021. Click here to request.
This web search service is supported by Google Inc.